trump glp 1 deal GLP-1 price reduction: President announces to reduce costs The $50 GLP-1 Rollout: Dr.

Credits: istock.org

Originally developed and positioned as treatments for type 2 diabetes, these agents are now equally associated with weight management, reshaping how clinicians, patients, and pharmacies understand metabolic disease

Eli Lillys first nine months of 2025 underscored the scale of the GLP-1 surge: Mounjaro and Zepbound generated $39.5 billion in revenue and surpasses Mercks Keytruda as the worlds best-selling medicine[5]

(BPT) At just 30 years old, Gabby weighed 299 pounds and was prediabetic

In collaboration with Novo Nordisk, Hims & Hers soon will offer access to the only FDA-approved GLP-1 weight loss pill, alongside injectable Wegovy in all dosages

Co-medication analysis revealed 81 cases with antidepressants, antipsychotics, and benzodiazepines, which may be proxies of mental health comorbidities